Clinical Trial Update: Safety and Immunogenicity Study of a Ross River Virus (RRV) Vaccine [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 safety and immunogenicity study of a Ross River Virus vaccine has completed, reporting initial safety data and immune responses.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ross River Virus Disease

Drugs mentioned

• Ross River virus vaccine

Snippet

Sponsor: Alachua Government Services, Inc. | Conditions: Ross River Virus Disease (RRVD) | Phase 1, Phase 2 | Status: COMPLETED